Evidence map›Paper›PMID 35182758›Full record

ArticleClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2022

Effective bubble-based testing for SARS-CoV-2 using swab-pooling.

Yuval Cohen, Nadav Bamberger, Orna Mor, Ronen Walfisch, Shay Fleishon, Itay Varkovitzky, Asaf Younger, Danit Oz Levi, Yishai Kohn, David M Steinberg and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 1 country.

Yuval CohenDirectorate of Defense Research & Development, Israeli Ministry of Defense, Tel Aviv, Israel.
Nadav BambergerDirectorate of Defense Research & Development, Israeli Ministry of Defense, Tel Aviv, Israel.
Orna MorCentral Virology Laboratory, Ministry of Health, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: Orna.Mor@sheba.health.gov.il.
Ronen WalfischDirectorate of Defense Research & Development, Israeli Ministry of Defense, Tel Aviv, Israel.
Shay FleishonIndependent Researcher, Jerusalem, Israel.
Itay VarkovitzkyDirectorate of Defense Research & Development, Israeli Ministry of Defense, Tel Aviv, Israel.
Asaf YoungerMyHeritage Lab, Petach Tikva, Israel.
Danit Oz LeviMyHeritage Lab, Petach Tikva, Israel.
Yishai KohnDirectorate of Defense Research & Development, Israeli Ministry of Defense, Tel Aviv, Israel.
David M SteinbergDepartment of Statistics and Operations Research, Tel Aviv University, Tel Aviv, Israel.
Danny ZeeviDepartment of Biotechnology, Hadassah Academic College, Jerusalem, Israel.
Oran ErsterCentral Virology Laboratory, Ministry of Health, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Ella MendelsonCentral Virology Laboratory, Ministry of Health, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Zvi LivnehDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel. Electronic address: zvi.livneh@weizmann.ac.il.
Ministry of Defense · ILMisgav Ladach · ILSheba Medical Center · ILTel Aviv University · ILHadassah Academic College · ILJerusalem Institute for Israel Studies · ILWeizmann Institute of Science · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesDespite the success in developing COVID-19 vaccines, containment of the disease is obstructed worldwide by vaccine production bottlenecks, logistics hurdles, vaccine refusal, transmission through unvaccinated children, and the appearance of new viral variants. This underscores the need for effective strategies for identifying carriers/patients, which was the main aim of this study.

methodsWe present a bubble-based PCR testing approach using swab-pooling into lysis buffer. A bubble is a cluster of people who can be periodically tested for SARS-CoV-2 by swab-pooling. A positive test of a pool mandates quarantining each of its members, who are then individually tested while in isolation to identify the carrier(s) for further epidemiological contact tracing.

resultsWe tested an overall sample of 25 831 individuals, divided into 1273 bubbles, with an average size of 20.3 ± 7.7 swabs/test tube, obtaining for all pools (≤37 swabs/pool) a specificity of 97.5% (lower bound 96.6%) and a sensitivity of 86.3% (lower bound 78.2%) and a post hoc analyzed sensitivity of 94.6% (lower bound 86.7%) and a specificity of 97.2% (lower bound 96.2%) in pools with ≤25 swabs, relative to individual testing. DISCUSSION: This approach offers a significant scale-up in sampling and testing throughput and savings in testing cost, without reducing sensitivity or affecting the standard PCR testing laboratory routine. It can be used in school classes, airplanes, hospitals, military units, and workplaces, and may be applicable to future pandemics.

Indexed as

COVID-19SARS-CoV-2ChildCOVID-19 TestingCOVID-19 VaccinesHumansPandemicsRNA, ViralSensitivity and SpecificitySpecimen HandlingCOVID-19 VaccinesRNA, ViralBubbleCapsuleCorona testingCOVID-19Pool testingSARS-CoV-2Swab pooling

Identifiers

PMID35182758
PMCPMC8849906
OpenAlexW4213051531

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.